NanoVibronix, Inc. announced that independent life expectancy testing performed by Carmel Labs in Israel confirm that its PainShield met all tested functionalities.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.721 USD | +1.76% |
|
+3.00% | -37.30% |
1st Jan change | Capi. | |
---|---|---|
-37.30% | 19.73L | |
-6.05% | 18TCr | |
-5.73% | 9.9TCr | |
-6.64% | 6.61TCr | |
-8.71% | 4.41TCr | |
+7.92% | 4.38TCr | |
+10.10% | 4.27TCr | |
+11.30% | 2.89TCr | |
+18.89% | 2.51TCr | |
-8.59% | 2.34TCr |
- Stock Market
- Equities
- NAOV Stock
- News NanoVibronix, Inc.
- NanoVibronix, Inc. Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services